Stock Price
14.74
Daily Change
0.05 0.34%
Monthly
13.04%
Yearly
-45.31%
Q2 Forecast
14.62

Telix Pharmaceuticals reported AUD1.37M in Interest Income for its fiscal semester ending in June of 2024.





Interest Income Change Date
Cochlear AUD 7.4M 2.2M Dec/2024
CSL USD 18M 1000K Dec/2024
Integral Diagnostics AUD 482K 103K Jun/2024
Medical Developments International AUD 174K 31K Dec/2024
Mesoblast USD 921K 18K Jun/2024
Pacific Edge NZD 1.19M 348K Sep/2024
ResMed USD 59K 4K Jun/2021